178 related articles for article (PubMed ID: 15985034)
1. 4% hydroquinone versus 4% hydroquinone, 0.05% dexamethasone and 0.05% tretinoin in the treatment of melasma: a comparative study.
Astaneh R; Farboud E; Nazemi MJ
Int J Dermatol; 2005 Jul; 44(7):599-601. PubMed ID: 15985034
[No Abstract] [Full Text] [Related]
2. A practical comparison of hydroquinone-containing products for the treatment of melasma.
Abramovits W; Barzin S; Arrazola P
Skinmed; 2005; 4(6):371-6. PubMed ID: 16276155
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma.
Cestari T; Adjadj L; Hux M; Shimizu MR; Rives VP
J Drugs Dermatol; 2007 Feb; 6(2):153-60. PubMed ID: 17373174
[TBL] [Abstract][Full Text] [Related]
4. Raman spectroscopy analysis of the skin of patients with melasma before standard treatment with topical corticosteroids, retinoic acid, and hydroquinone mixture.
Moncada B; Castillo-Martínez C; Arenas E; León-Bejarano F; Ramírez-Elías MG; González FJ
Skin Res Technol; 2016 May; 22(2):170-3. PubMed ID: 26179661
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of retinoic acid in the treatment of melasma.
Pathak MA; Fitzpatrick TB; Kraus EW
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):894-9. PubMed ID: 3534025
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States.
Alikhan A; Daly M; Wu J; Balkrishnan R; Feldman SR
J Dermatolog Treat; 2010 Sep; 21(5):276-81. PubMed ID: 20055711
[TBL] [Abstract][Full Text] [Related]
7. A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream.
Bhawan J; Grimes P; Pandya AG; Keady M; Byers HR; Guevara IL; Colón LE; Johnson LA; Gottschalk R
Am J Dermatopathol; 2009 Dec; 31(8):794-8. PubMed ID: 19755910
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
[TBL] [Abstract][Full Text] [Related]
10. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
[TBL] [Abstract][Full Text] [Related]
11. Rationale for the use of topical corticosteroids in melasma.
Menter A
J Drugs Dermatol; 2004; 3(2):169-74. PubMed ID: 15098972
[TBL] [Abstract][Full Text] [Related]
12. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
Nanda S; Grover C; Reddy BS
Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
[TBL] [Abstract][Full Text] [Related]
14. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Draelos Z
Dermatol Surg; 2011 Jan; 37(1):126-7. PubMed ID: 21214668
[No Abstract] [Full Text] [Related]
15. Improved quality of life with effective treatment of facial melasma: the pigment trial.
Balkrishnan R; Kelly AP; McMichael A; Torok H
J Drugs Dermatol; 2004; 3(4):377-81. PubMed ID: 15303781
[TBL] [Abstract][Full Text] [Related]
16. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Monheit GD; Dreher F
J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
[TBL] [Abstract][Full Text] [Related]
18. Community-based trial of a triple-combination agent for the treatment of facial melasma.
Grimes P; Kelly AP; Torok H; Willis I
Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738
[TBL] [Abstract][Full Text] [Related]
19. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Grimes PE
Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
[TBL] [Abstract][Full Text] [Related]
20. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
Rendon M; Dryer L
J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
